17 Feb 2018

MERZ NA TO HIGHLIGHT TREATMENTS AT AAD ANNUAL MEETING

  Merz North America aesthetics products including Xeomin, Cellfina, Radiesse, Ultherapy and DeScribe PFD Patch will be featured in oral and online ePoster presentations at the American Academy of Dermatology (AAD) annual meeting in San Diego, CA, taking place Feb. 16-20. “Each year, AAD provides Merz with the opportunity to

0
15 Feb 2018

ANGIODYNAMICS TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE

AngioDynamics, Inc. , a provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, has announced that Jim Clemmer, president and CEO, and Michael C. Greiner, executive vice president and CFO, will present at the Barclays Global Healthcare Conference at 3:20 p.m. ET on Tuesday, March

0
15 Feb 2018

IAC RESEARCH LETTER OF INTENT DEADLINE APRIL 2

  The deadline for submitting a letter of tenant to submit a full research program proposal to be funded by the Intersocietal Accreditation Commission (IAC) is April 2. The IAC Research Committee will be awarding one-year grants or continuation grants up to a maximum of $75,000 (including institutional overhead). This

0
08 Feb 2018

16th IVC TO HOST 800+ VEIN CARE SPECIALISTS TO LEARN LATEST DEVELOPMENTS IN VENOUS DISEASE MANAGEMENT

  By Larry Storer The International Vein Congress (IVC) will host its 16th annual meeting April 19-21 in Miami Beach, Fla., at the Loews Miami Beach Hotel in collaboration with the Society for Vascular Surgery (SVS). Jose I. Almeida, MD, FACS, RPVI, RVT, who founded the conference and has directed

0
30 Jan 2018

ACP OFFERS ONE-DAY PRACTICE MANAGEMENT COURSE

  A Practice Management Course, a one-day series covering topics vital to a vein practice, will be conducted by the American College of Phlebology from 8-5 p.m. March 3 at the Denver Airport Marriott at Gateway Park in Aurora, Colo. Register at https://netforum.avectra.com/eweb/DynamicPage.aspx?WebCode=LoginRequired&Site=ACP

0
18 Jan 2018

JACKSON HEALTHCARE PUTS DR. TOM PRICE ON ADVISORY BOARD

  Tom Price, MD, who resigned in September as secretary of the Department of Health and Human Services (HHS), has been named to the advisory board of an Atlanta-based staffing firm. Dr. Price, a former orthopedic surgeon and congressman, stepped down from his high-profile post as head of the HHS after only

0
17 Jan 2018

SENATE COMMITTEE APPROVES ALEX AZAR TO HEAD HHS

The U.S. Senate Finance Committee voted 15-12 to approve the nomination of Alex Azar to be the next Secretary of the Department of Health and Human Services (HHS) Jan. 17. Only one Democrat, Tom Carper of Delaware, assented to Azar’s nomination, joining the panel’s Republicans. The committee vote sets up

0
12 Jan 2018

CENTERLINE BIOMEDICAL  COMPLETES FIFTH STUDY ON IOPS SURGICAL NAVIGATION SYSTEM AT CLEVELAND CLINI

  Endovascular navigation startup Centerline Biomedical has successfully completed a fifth preclinical study at Cleveland Clinic facilities to see how its surgical navigation system, the Intra-Operative Positioning System (IOPS), will perform in the marketplace. The study demonstrated its ability to track IOPS instruments precisely and efficiently with enhanced three-dimensional (3D) visualization and

0
11 Jan 2018

FDA APPROVES XABLECATH BLUNT TIP SUPPORT CATHETER

  XableCath’s blunt tip support catheter has received clearance from the U.S. Food and Drug Administration (FDA). In two clinical investigator-led studies, the device was demonstrated to be a safe, effective, and easy-to-use device, enabling therapeutic options for patients with PAD,” said Johannes Dahm, MD and director of Interventional Cardiology

0
06 Jan 2018

STUDY SHOWS STEM CELL TRANSPLANT IS BETTER THAN DRUG THERAPY FOR SCLERODERMA

Photo courtesy of American College of Rheumatology   Adding irradiation before transplant improves long-term results and should change practice    Scleroderma with internal organ involvement is a debilitating and lethal autoimmune disorder with few effective treatments. But a study led by Duke Health researchers has found new cause for optimism using an

0